Navigation Links
A New Technique For Prediction Of Adult Height

A number of methods exist to predict how tall a child can be after maturity. However, these are invasive, expensive, or relatively imprecise. Previous methods have used //secondary sexual characteristics as a marker of maturity, but they lack precision, as well as being invasive. The current ‘gold standard’, utilizing skeletal age, requires radiological measurement of bone age to account for variation in biological maturity.

Recently a new technique has been developed for prediction of height. The study, published in the October issue of The Journal of Pediatrics was designed to validate and demonstrate how adult height can be predicted by using reference values obtained from maturity and sex-specific cumulative height velocity curves.

For the study, serial height measurements were taken on 224 boys and 120 girls. Individuals were classified as early, average, or late maturers, depending on their age of peak height velocity. Maturity and sex-specific cumulative height velocity curves were developed for early, average, and late maturers, and the area under these curves (AUCs) were used to develop reference values to predict adult height.

The authors claim that this method can predict adult height within ± 5.35 cm 95% of the time in boys and ± 6.81 cm 95% of the time in girls.

The technique is advantageous in that it includes a measure of biological age, and is a valid, non-intrusive, inexpensive, and simple method of predicting adult height in adolescent children, free of growth limiting disease.
'"/>




Page: 1

Related medicine news :

1. New Laser Techniques cure degeneration of the eye
2. New Technique to Study Infants Brain.
3. New Technique For Benign Breast Tumors
4. Preventing Strokes Using Less Invasive Techniques
5. New Technique To Detect Activity Of Drugs In The Body
6. New Technique To Test Stem Cells That Heal The Heart
7. Novel Technique For Targeting Small-Cell Lung Cancer
8. Novel Technique For Management Of Inverted Papilloma Of Frontal Sinus
9. New Cardiac Angiography Technique For Improved Imaging Of Coronary Veins
10. New Technique Enables Better Nursing Of Robin Sequence Infants
11. Novel Technique Can Enhance Stem Cell Multiplication By 30 Fold
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...s C has become the scourge of multitude of Queensl...elentless battle with the disease//, underlining t... successful treatment of the disease. Hepatitis C... liver, which can also turn fatal. The University ...
...le against polio is far from over in Bihar with th...re not covered in the June-July immunisation drive...divisions were not covered under the drive.Two new..., while one each came up in Arwal and Nawada distr...
...cannot be prevented just by giving young children ...nducted by researchers in Glasgow//. The findings ... are contrary to the popular assumption that in th...television and computer games, children could shed...
...g to a survey, mental health wards have been grade...t mental health inpatients//. The charity called ...action over the state of repair of their ward whil...andards of hygiene.Mind is for patients to be trea...
Other Medicine News:Health News:More Exercise does not Prevent Obesity in Children 2Health News:Mental Health Wards rated unpleasant 2
(Date:10/8/2008)...indings May Someday Inform Treatments for Spinal C... /PRNewswire-USNewswire/ -- A protein that enables...a key role in controlling,the developing nervous s...e,connections to form among nerve cells may provid... suffer injuries to their nervous system,includin...
(Date:10/8/2008)...ornell University Food Scientists Expand Testing U...tivity Assay, PORTLAND, Maine, Oct. 8 /PRNewswire...today with the release of results from a new study...er commonly consumed,fruits like apples, bananas, ...ing the Cellular Antioxidant Activity (CAA) assay....
(Date:10/8/2008)...N, France, Oct. 8 /- Vical Incorporat...linical data and new nonclinical data,demonstratin...broadly,applicable in DNA- and protein-based infec...ccines. Alain P. Rolland, Pharm.D., Ph.D., Vical,s...l present the data today,Wednesday, October 8, at...
(Date:10/7/2008)...NT, Mich., Oct. 7 /- McLaren Health C...ring some of the world,s leading medical,minds to ... breast and,gastrointestinal cancer treatments. Th...CI, was organized by McLaren,s Sukamal Saha, M.D.,...n sentinel node mapping for,colorectal cancer has ...
Breaking Medicine Technology:Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Data Show ARIMIDEX 28R 29 28Anastrozole 29 Continues To Be Superior to Tamoxifen in Helping Reduce the Risk of Recurrence in Patients With Early Brea 8319 1Data Show ARIMIDEX 28R 29 28Anastrozole 29 Continues To Be Superior to Tamoxifen in Helping Reduce the Risk of Recurrence in Patients With Early Brea 8319 2Data Show ARIMIDEX 28R 29 28Anastrozole 29 Continues To Be Superior to Tamoxifen in Helping Reduce the Risk of Recurrence in Patients With Early Brea 8319 3Data Show ARIMIDEX 28R 29 28Anastrozole 29 Continues To Be Superior to Tamoxifen in Helping Reduce the Risk of Recurrence in Patients With Early Brea 8319 4GeneSeek Selects the British Midlands as Base for New UK European Operations 2219 1GeneSeek Selects the British Midlands as Base for New UK European Operations 2219 2GeneSeek Selects the British Midlands as Base for New UK European Operations 2219 3Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 1Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 2Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 3Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers 24100 Million Cut in FY 2008 Budget for Its 2217 4Study Finds Cholesterol Fine Tunes Hearing 8316 1Study Finds Cholesterol Fine Tunes Hearing 8316 2
...l Studies Suggest FTY720 Mechanisms in Multiple,Sc... · Preclinical studies suggest FTY720 stimu... and enhance repair of the,CNS affected by multipl...he six-month multiple,sclerosis Phase II clinical ...linical depression was significantly lower in the,...
..., N.J.--(BUSINESS WIRE)--May 4, 2007 - Lux Bioscie... specialized in the,field of ophthalmic diseases, ... calcineurin inhibitor, LX211, is the subject of t...n Vision and,Ophthalmology (ARVO) annual meeting, ...The first, an oral presentation being given on May...
Other Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 2Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 3Lux Biosciences' Investigational Therapy for Uveitis, LX211, is,Subject of Two Presentations at Key Ophthalmology Meeting, ARVO,2007 4
The ENDOLOOP consists of 18'' long ligature inserted into a plastic tube. The plastic tube is narrow at one end and scored on the other. The suture protrudes from the narrow end and is formed in a li
VIDAS tests are presented in individual, ready to use form. Each test is composed of a strip and a SPR. The strip contains all the reagent required for the reaction (buffer, conjugate and substrate.
Clostridium difficile Toxin A Rapydtest® is a fast, simple and highly sensitive test for the rapid and reliable detection of C. difficile Toxins A in faeces.
The RC-4000 guarantees precise and efficient multi-diagnostic measurement by combining keratometry, refraction, refraction/keratometry and contact lens base curve measurement.
Medicine Products: